ArticleOPEN ACCESS

Prophylactic tocilizumab to prevent cytokine release syndrome (CRS) with teclistamab: A single-center experience

Blood Cancer Journal
DOI: 10.1038/s41408-023-00963-y
41Citations
Citations of this article
29Readers
Mendeley users who have this article in their library.

This article is free to access.

Cite

CITATION STYLE

APA

Scott, S. A., Marin, E. M., Maples, K. T., Joseph, N. S., Hofmeister, C. C., Gupta, V. A., … Nooka, A. K. (2023, December 1). Prophylactic tocilizumab to prevent cytokine release syndrome (CRS) with teclistamab: A single-center experience. Blood Cancer Journal. Springer Nature. https://doi.org/10.1038/s41408-023-00963-y

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free